Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Rigrodsky & Long, P.A. Announces Investigation of American Medical Alert Corp

VIEWS: 5 PAGES: 2

WILMINGTON, Del.--(EON: Enhanced Online News)--Rigrodsky & Long, P.A. announces its investigation of potential claims against the board of directors of American Medical Alert Corp. (Nasdaq: AMAC) regarding its sale to Tunstall Healthcare Group Ltd img border='0' title='Add to Go

More Info
									Rigrodsky & Long, P.A. Announces Investigation
of American Medical Alert Corp.
September 23, 2011 03:44 PM Eastern Daylight Time 

WILMINGTON, Del.--(EON: Enhanced Online News)--Rigrodsky & Long, P.A. announces that it is investigating
potential claims against the board of directors of American Medical Alert Corp. (“AMAC” or the “Company”)
(Nasdaq: AMAC) concerning possible breaches of fiduciary duty and other violations of law related to the
Company’s entry into an agreement to be acquired by Tunstall Healthcare Group Limited (“Tunstall”) in a
transaction with an approximate value of $82.3 million.

Click here to learn more and how to join the action:
http://investigations.rigrodskylong.com/americanmedicalalertcorp-amac/.

Under the proposed agreement, AMAC shareholders will receive $8.55 per share in cash for every share of AMAC
common stock they hold plus one Contingent Payment Right (CPR) per share providing a contingent cash payment
for the holder of such common share in the event of a sale of AMAC’s interests in the Lifecomm joint venture or
prior sale of Tunstall under certain conditions.

The investigation concerns whether AMAC’s board of directors adequately shopped the Company to obtain the
best price possible for AMAC’s shareholders before entering into the agreement with Tunstall. Indeed, in
conjunction with the acquisition, directors and officers of AMAC, holding approximately 26% of the outstanding
common shares of AMAC, have agreed to vote in favor of the transaction.

If you own the common stock of AMAC and purchased your shares before September 22, 2011, if you have
information or would like to learn more about these claims, or if you wish to discuss these matters or have any
questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth
D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N.
Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to
info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates
securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation,
including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and
federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contacts
Rigrodsky & Long, P.A.
Seth D. Rigrodsky, Esquire
Noah R. Wortman, Case Development Director
888-969-4242
302-295-5310
Fax: 302-654-9430
info@rigrodskylong.com
http://www.rigrodskylong.com

Recent Stories from Rigrodsky & Long, P.A.
l

    Rigrodsky & Long, P.A. Files Class Action Lawsuit Against OPENLANE, Inc.
    September 16, 2011
    WILMINGTON, Del.--(EON: Enhanced Online News)--Rigrodsky & Long, P.A. has filed a class action
    lawsuit in the Delaware Court of Chancery against the OPENLANE, Inc. (OTC Pink: OPNN) board of
    directo... more »
l

    Rigrodsky & Long, P.A. Investigates JAKKS Pacific, Inc.
    September 14, 2011
    WILMINGTON, Del.--(EON: Enhanced Online News)--Rigrodsky & Long, P.A. announces its
    investigation of potential claims against the board of directors of JAKKS Pacific, Inc. (Nasdaq: JAKK)
    regarding ... more »
l

    Rigrodsky & Long, P.A. Investigates Venoco, Inc.
    August 29, 2011
    WILMINGTON, Del.--(EON: Enhanced Online News)--Rigrodsky & Long, P.A. announces its
    investigation of potential claims against the board of directors of Venoco, Inc. (NYSE: VQ) re: its receipt of
    a ... more »

								
To top